CDMO SERVICES
Exosome Manufacturing Platform

Exosome Manufacturing Platform

             
       

Bridging Exosomes Innovation to Clinic with the ExoMX™ Platform
       

To overcome the manufacturing challenges of MSC-EV products in clinical translation, we have developed ExoMX, a state-of-the-art, scalable, and GMP-compliant platform. This platform integrates a 3D microcarrier-based bioreactor process with TFF and chromatography-based purification to ensure high-quality EV production.
       
       

Industrialized EV Production: Accelerate Market Entry by Advanced 3D Bioreactor Technology
 

With 3D-boosting technology and streamlined bioreactor manufacturing capabilities ranging from 0.25L to 50L scale, we support product development path into clinical use.

 

  • Over 5-fold of MSC-EV productivity by 3D-boosting technology
  • Enable large-scale EV production achieving 400 trillion EV per 50 L batch
  • Closed and automated bioreactor process with real-time control
  • Lot-to-lot quality consistency
  • Xeno-free and chemical-defined process
 
     
  Streamlined 3D Bioreactor Solutions  
         
  Productivity   Cost-effectiveness  
         
  3D bioreactors achieving over 5-fold higher MSC-EV productivity compared to traditional 2D culture methods.   3D bioreactor system offers significant labor, space and time efficiency. A single 50L unit can produce the same yield as 225 traditional CellSTACK-10 units, enabling EV production to reach 4 x 10¹⁴.  
         
     
         

 
 

Flexible Solutions for every stage
 

We offer phase-appropriate manufacturing, versatile purification strategies, formulation development FAST TRACK service and tailored analytical services. Built on GMP principles, our step-by-step approach minimizes risk and accelerates your path to market.
 

 
 

Phase-appropriate Manufacturing Scales
 

Enabling seamless advancement from early R&D to clinical transition.
 

 
Versatile Exosome Purification Strategies

 
 

Downstream processing is critical for final yield, batch consistency, and product potency. Our experts develop scalable, customized workflows from medium harvest, exosome purification and vialing. With advanced equipment and expertise, we tailor every step to meet your specific needs.
 
 
Analytical Services

 
 

We offer comprehensive EV Characterization Packages, including Base and Plus options. All assays can be chosen individually as you need.
 
 

From Click to Delivery — Your Exosomes, in 30 Days.
 

Accelerate your research with Mycenax's Exosome Express Service — a fast, flexible, and high-quality solution for obtaining human MSC-derived exosomes. Powered by our ExoMX™ platform, pre-established human MSC research cell banks, and a xeno-free, chemically defined process, we offer both customized and ready-to-ship options to meet your specific needs.
 

 

 

 

 

 

     
   
     
  What are exosomes?  
     
  Exosomes are small extracellular vesicles (EV) that play a crucial role in cell-to-cell communication and hold great potential for early diagnosis, prognosis, and targeted therapy. Their unique properties make them a promising next-generation biologic.  
     
     
  Bridging Exosomes Innovation to Clinic with the ExoMX™ Platform  
     
  To overcome the manufacturing challenges of MSC-EV products in clinical translation, we have developed ExoMX, a state-of-the-art, scalable, and GMP-compliant platform. This platform integrates a 3D microcarrier-based bioreactor process with TFF and chromatography-based purification to ensure high-quality EV production.  
     
   
     
   
     
   
     
   
     
  Industrialized EV Production: Accelerate Market Entry by Advanced 3D Bioreactor Technology  
     
   
     
 

With 3D-boosting technology and streamlined bioreactor manufacturing capabilities ranging from 0.25L to 50L scale, we support product development path into clinical use.

 

  • Over 5-fold of MSC-EV productivity by 3D-boosting technology
  • Enable large-scale EV production achieving 400 trillion EV per 50 L batch
  • Closed and automated bioreactor process with real-time control
  • Lot-to-lot quality consistency
  • Xeno-free and chemical-defined process
  
     
   
     
  Flexible Solutions for every stage  
     
  We offer phase-appropriate manufacturing, versatile purification strategies, and tailored analytical services. Built on GMP principles, our step-by-step approach minimizes risk and accelerates your path to market.  
     
   
     
  Phase-appropriate Manufacturing Scales  
     
 

Enabling seamless advancement from early R&D to clinical transition.
   
 
   
   
 
   
 

Versatile Exosome Purification Strategies
     
 

Downstream processing is critical for final yield, batch consistency, and product potency. Our experts develop scalable, customized workflows from medium harvest, exosome purification and vialing. With advanced equipment and expertise, we tailor every step to meet your specific needs.
   
 
   
   
 
 

Learn More →
   
   
 
   
 

Analytical Services
     
 

We offer comprehensive EV Characterization Packages, including Base and Plus options. All assays can be chosen individually as you need.
   
 
   
 

From Click to Delivery — Your Exosomes, in 30 Days.
   
 

Accelerate your research with Mycenax's Exosome Express Service — a fast, flexible, and high-quality solution for obtaining human MSC-derived exosomes. Powered by our ExoMX™ platform, pre-established human MSC research cell banks, and a xeno-free, chemically defined process, we offer both customized and ready-to-ship options to meet your specific needs.
   
 
   
 
   
 

 
 

 

確認送出 SEND
GO TOP